AksuUGulcuOAksakalEKalkanK. Endocan and major adverse cardiovascular events: understanding regression methods. Angiology. 2019: 0003319719828911
2.
PakzadRAshrafi-AsgarabadASafiriS. The prognostic impact of uric acid in patients with severely decompensated acute heart failure; methodological issues. J Cardiol. 2017;70(2):199.
3.
KutnerMHNachtsheimCJNeterJ, et al.Applied Linear Statistical Models. 5th ed. Pennsylvania Plaza, NY: McGraw-Hill Irwin Boston; 2005.
4.
ZiaeeMMashayekhiSGhaffariSMahmoudiJSarbakhshPGarjaniA. Predictive value of endocan based on TIMI risk score on major adverse cardiovascular events after acute coronary syndrome. Angiology. 2019;70(10):936–43.
